Allan SG, Rodger A, Smyth JF, et al,
"Tamoxifen as Primary Treatment of Breast Cancer in Elderly or Frail Patients: A Practical Management,"
Br Med J [Clin Res], 1985, 290:358.
Buckley MM and Goa KL,
"Tamoxifen. A Reappraisal of Its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Use,"
Drugs, 1989, 37(4):451-90.
Catherino WH and Jordan VC,
"A Risk-Benefit Assessment of Tamoxifen Therapy," Drug Saf, 1993,
8(5):381-97.
Cohen I, Altaras MM, Lew S, et al,
"Ovarian Endometrioid Carcinoma and Endometriosis Developing in a Postmenopausal Breast Cancer Patient During Tamoxifen Therapy: A Case Report and Review of the Literature,"
Gynecol Oncol, 1994, 55(3 Pt 1):443-7.
Cutuli B, Petit JC, Fricker JP et al,
"Thromboembolic Accidents in Postmenopausal Patients Treated by Tamoxifen and Adjuvant Treatment: Frequency, Risk Factors, and Prevention,"
Bull Cancer, 1995, 82(1):51-6.
Cuzick J, Allen D, Baum M, et al,
"Long Term Effects of Tamoxifen: Biological Effects of Tamoxifen Working Party,"
Eur J Cancer, 1992, 29A(1):15-21.
Dew JE and Eden JA,
"Gynaecological Complications of Women Treated With Tamoxifen for Breast Cancer,"
Aust N Z J Obstet Gynaecol, 1995, 35(2):198-200.
Fernando IN and Tobias JS, "Priapism in Patient on Tamoxifen," Lancet,
1989, 1(8635):436.
Folk JJ, Mazur MT, Eddy GL, et al,
"Secretory Endometrial Adenocarcinoma in a Patient on Tamoxifen for Breast Cancer: A Report of a Case,"
Gynecol Oncol, 1995, 58(1):133-5.
Gelmann EP,
"Tamoxifen for the Treatment of Malignancies Other Than Breast and Endometrial Carcinoma,"
Semin Oncol, 1997, 24(1 Suppl 1):S1-65-S1-70.
Hochner-Celnikier D, Anteby E, and Yagel S,
"Ovarian Cysts in Tamoxifen-Treated Premenopausal Women With Breast Cancer - A Management Dilemma,"
Am J Obstet Gynecol, 1995, 172(4 Pt 1):1323-4.
Jeffrey LP, Chairman, National Study Commission on Cytotoxic Exposure.
Position Statement.
"The Handling of Cytotoxic Agents by Women Who Are Pregnant, Attempting to Conceive, or Breast-Feeding,"
January 12, 1987.
Jordan VC,
"Tamoxifen: Toxicities and Drug Resistance During Treatment and Prevention of Breast Cancer,"
Annu Rev Pharmacol Toxicol, 1995, 35:195-211.
LiVolsi VA, Salhany KE, and Dowdy YG,
"Endocervical Adenocarcinoma in Tamoxifen-Treated Patient," Am J Obstet
Gynecol, 1995, 172(3):1065.
Nease RF Jr and Ross JM,
"The Decision to Enter a Randomized Trial of Tamoxifen for the Prevention of Breast Cancer in Healthy Women: An Analysis of the Tradeoffs,"
Am J Med, 1995, 99(2):180-9.
Parry BR, "Radiation Recall Induced by Tamoxifen," Lancet, 1992,
340(8810):49.
Pratt DS, Knox TA, and Erban J, "Tamoxifen-Induced Steatohepatitis," Ann
Intern Med, 1995, 123(3):236.
Rabinowicz AL, Hinton DR, Dyck P, et al,
"High-Dose Tamoxifen in Treatment of Brain Tumors: Interaction With Antiepileptic Drugs,"
Epilepsia, 1995, 36(5):513-5.
Ritchie LD and Grant SM,
"Tamoxifen-Warfarin Interaction: The Aberdeen Hospitals Drug File," BMJ,
1989, 298(6682):1253.
Rutqvist LE, Johansson H, Signomklao T, et al,
"Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies. Stockholm Breast Cancer Study Group,"
J Natl Cancer Inst, 1995, 87(9):645-51.
Rutqvist LE, "Long-Term Toxicity of Tamoxifen," Recent Results Cancer
Res, 1993, 127:257-66.
Spooner D and Evans BD, "Tamoxifen and Life-Threatening Hypercalcaemia,"
Lancet, 1979, 2(8139):413-4.
Taylor SG, Gelman RS, Falkson G, et al,
"Combination Chemotherapy Compared to Tamoxifen as Initial Therapy for Stage IV Breast Cancer in Elderly Women,"
Ann Intern Med, 1986, 104:455-61.
Wogan GN, "Review of the Toxicology of Tamoxifen," Semin Oncol, 1997,
24(1 Suppl 1):S1-87-S1-97.